Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Acehytisine"'
Autor:
Cao, Xin, Nagasawa, Yoshinobu, Zhang, Chengshun, Zhang, Hanxiao, Aimoto, Megumi, Takahara, Akira
Publikováno v:
In Journal of Pharmacological Sciences January 2020 142(1):34-40
Autor:
Cao, Xin, Nagasawa, Yoshinobu, Zhang, Chengshun, Zhang, Hanxiao, Aimoto, Megumi, Takahara, Akira
Publikováno v:
In Journal of Pharmacological Sciences December 2019 141(4):153-159
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pharmacological Sciences, Vol 142, Iss 1, Pp 34-40 (2020)
Atrial dilation is an independent risk factor for the development of atrial fibrillation (AF) and modulates the efficacy of anti-AF drugs, leading to the unsatisfactory control of AF. Pre-clinical studies showed anti-AF effects of acehytisine, a mult
Externí odkaz:
https://doaj.org/article/5fec907baf0b47ad9931a27942314ece
Autor:
Xinrong Fan, Chao Wang, Na Wang, Xianhong Ou, Hanxiong Liu, Yan Yang, Xitong Dang, Xiaorong Zeng, Lin Cai
Publikováno v:
Journal of Pharmacological Sciences, Vol 132, Iss 4, Pp 235-243 (2016)
Acehytisine, a multi-ion channel blocker, can markedly inhibit INa, ICa, IKur, If at various concentrations and effectively terminate and prevent atrial fibrillation (AF) in patients and animal models, but the molecular mechanism underlying its block
Externí odkaz:
https://doaj.org/article/4fb6e00e446741ccb9ab48f6e7b9e2ac
Autor:
Fan, Xinrong, Wang, Chao, Wang, Na, Ou, Xianhong, Liu, Hanxiong, Yang, Yan, Dang, Xitong, Zeng, Xiaorong, Cai, Lin
Publikováno v:
In Journal of Pharmacological Sciences December 2016 132(4):235-243
Publikováno v:
Journal of Pharmacological Sciences, Vol 141, Iss 4, Pp 153-159 (2019)
Experimental evidence regarding the risk of proarrhythmic potential of acehytisine is limited. We assessed its electropharmacological effect together with proarrhythmic potential at intravenous doses of 4 and 10 mg/kg (n = 6) using isoflurane-anesthe
Externí odkaz:
https://doaj.org/article/ba52a1dff6c04d0fa95f0fa1effc4974
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Feb2009, Vol. 104 Issue 2, p145-154. 10p. 1 Diagram, 5 Charts, 6 Graphs.
Publikováno v:
Journal of Pharmacological Sciences, Vol 142, Iss 1, Pp 34-40 (2020)
Atrial dilation is an independent risk factor for the development of atrial fibrillation (AF) and modulates the efficacy of anti-AF drugs, leading to the unsatisfactory control of AF. Pre-clinical studies showed anti-AF effects of acehytisine, a mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb1aa9bc6ccb8de03178a8c2e399375
https://doi.org/10.1016/j.jphs.2019.11.003
https://doi.org/10.1016/j.jphs.2019.11.003
Publikováno v:
Journal of Pharmacological Sciences, Vol 141, Iss 4, Pp 153-159 (2019)
Experimental evidence regarding the risk of proarrhythmic potential of acehytisine is limited. We assessed its electropharmacological effect together with proarrhythmic potential at intravenous doses of 4 and 10 mg/kg (n = 6) using isoflurane-anesthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e945367bde8ea843d7fb8a5305b0f7ae
https://doi.org/10.1016/j.jphs.2019.10.006
https://doi.org/10.1016/j.jphs.2019.10.006